Drugs / AEC/BC02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05284812 | Feb 2022 → Jun 2024 | tuberculosis | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Suspended | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AEC/BC02 | “A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)” NCT05284812 ↗ |
| Modality | Vaccine | “recombinant tuberculosis vaccine” NCT05284812 ↗ |
| Route | Intramuscular | “injection into the deltoid muscle of the upper arm” NCT05284812 ↗ |